期刊文献+

住院病人中常见病原菌的分布及耐药性分析 被引量:5

Distribution and antibiotic resistance of pathogenic bacteria isolated from inpatients
暂未订购
导出
摘要 目的了解住院病人常见细菌的菌群分布及耐药特征,为临床感染治疗提供参考依据。方法采用MicroScanAuto-Scan-40半自动微生物鉴定仪和药敏系统及配套进行菌株鉴定与药物敏感性测定,并检测ESBLs。结果2007年10—12月我院临床分离614株细菌中革兰阴性杆菌524(85.3%),革兰阳性球菌90株(14.7%)。革兰阴性杆菌中以大肠埃希菌占多数(152株),其余依次为肺炎克雷伯菌(100株)、鲍曼不动杆菌(80株)、铜绿假单胞菌(79株)。金葡菌(SA)和凝固酶阴性葡萄球菌(CNS)中甲氧西林耐药株(MRSA和MRCNS)各占30.3%和35.3%,未发现耐万古霉素的葡萄球菌和肠球菌;大肠埃希菌和克雷伯菌属产ESBLs的发生率为62.5%和32.0%,革兰阴性杆菌对大多数抗菌药物(除了亚胺培南)耐药率高。结论我院革兰阴性杆菌及革兰阳性球菌耐药性强且多重耐药,应合理应用抗生素并严密监控新的耐药菌的产生。 Objective To investigate the distribution and antibiotic resistance of clinical bacteria isolated from inpatients in our hospital. Methods Bacterial identification and antibiotic susceptibility testing were carried out using MicroScanAutoScan 40 system. ESBLs production was also determined. Results A total of 614 clinical isolates were analyzed, including 90 strains of grampositive cocci and 524 strains of gram-negative bacilli. The prevalence of methiciliin-resistant S. aureus and methicillin-resistant coagulase negative Staphylococcus was 30.3% and 35.3% respectively. No vancomycin-resistant Staphylococcus or Enterococcus strain was identified. ESBLs producing strains accounted for 62.5 % of E. coil and 32 % of Klebsiella. The gram negative bacilli strains were highly resistant to antimicrobial agents (except imipenem). Conclusions It is important to prescribe antibiotics rationally and monitor the antimicrobial resistance of clinical pathogens.
出处 《中国感染与化疗杂志》 CAS 2008年第6期456-458,共3页 Chinese Journal of Infection and Chemotherapy
关键词 细菌 抗菌药物 耐药性 Bacterium Antibacterial agent Drug resistance
  • 相关文献

参考文献5

二级参考文献27

  • 1刘杨,吴菊芳,萧正伦,盛瑞媛,吕晓菊,陈燕,张婴元.1031例患者应用去甲万古霉素不良反应观察[J].中华内科杂志,2004,43(11):815-819. 被引量:47
  • 2段利生,虎安定.喹诺酮类药物不良反应特征综述[J].中国药事,2005,19(2):117-119. 被引量:19
  • 3Craig WA. Pharmacokinetic/Pharmacyodynamic parameters:rationale for antibacterial dosing of mice and men[J]. Clin Infect Dis, 1998,26:1-10.
  • 4Zhanel GG. Influence of pharmacyokinetic and pharmacodynamic Principles on Antibiotic Selection[J]. Curr Infect Dis Rep, 2001,3: 29-34.
  • 5Tulkens PM. New strategies to avoid development of microbial resistance[C]. A symposium on resistance and the use and misuse of antimicrobial therapy, 2000,44-52.
  • 6Maglio D, Nightingale CH, Nicolau DP. Extended interval aminoglycoside dosing : from concept to clinic[J]. Int J Antimicrob Agents, 2002,19 : 341-348.
  • 7Prins JM, Speelman P. Once daily aminoglycosides: practical guideline[J]. Neth J Med, 1998,52 : 1-9.
  • 8Hierholzer WJ,Garner JS, Adams AB, et al. Recommendations for preventing the spread of vancomycin resistance:Recommendations of the HICPAC[J]. Am J Infect Control, 1995,23: 87-94.
  • 9HICPAC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin[J]. Morb Mortal Wkly Rep,2002,51:565-567.
  • 10Schaad UB,Abdus Salam M,Aujard Y,et al. Use of fluoroquinolones in pediatrics : Consensus report of an International Society of Chemotherapy commission[J]. Pediatr Infect Dis J, 1995,14:1-9.

共引文献171

同被引文献56

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部